Dr. Beverly Malone

As we celebrate the Year of the Nurse, it is only fitting that we honor Dr. Malone with NCHL’s most prestigious award, recognizing her dedication to leadership, organizational excellence and mentorship, and her strong advocacy to advance the cause of nursing

CHICAGO (PRWEB)
August 10, 2020

The National Center for Healthcare Leadership, a nonprofit organization that supports the advancement of evidence-based leadership practices, is pleased to announce that Dr. Beverly Malone, Chief Executive Officer of the National League for Nursing (NLN), has been named the 2020 Gail L. Warden Leadership Excellence Award recipient.

As head of the NLN, the premier organization for faculty and leaders in nursing education, Dr. Malone is recognized for forging partnerships with key educational institutions, corporations and foundations that keep the NLN on the cutting edge of the technological innovations that are needed by nurse educators to help them succeed in today’s rapidly changing environment. Under her leadership, the NLN, with 40,000 individual members and 1,200 institutional members, has moved to a mission-aligned business model that supports and develops nurses heading into leadership roles as well as building a diverse workforce dedicated to advancing the nation’s health.

Dr. Malone is a visible national and global thought leader on issues facing the nursing profession, including diversity, the nurse educator shortage, and workforce development. Her career has mixed policy, education, administration, and clinical practice, underscoring her commitment and contributions to improving the health of the public, and distinguishing her leadership excellence.

“Dr. Malone exemplifies transformational leadership as evidenced by her life-long career advancing innovation in nursing education and addressing national and global health issues, including workplace diversity,” NCHL CEO LeAnn Swanson said. “As we celebrate the Year of the Nurse, it is only fitting that we honor Dr. Malone with NCHL’s most prestigious award, recognizing her dedication to leadership, organizational excellence and mentorship, and her strong advocacy to advance the cause of nursing.”

Dr. Malone joined the National League for Nursing in 2007 after serving as General Secretary of the Royal College of Nursing of the United Kingdom in London, England, from 2001-2007. Prior to that, she was deputy assistant secretary for Health in the Department of Health and Human Services from 1999-2001, and served two terms as president of the American Nurses Association from 1996-2000. Earlier in her career, Dr. Malone held leadership roles at the North Carolina A&T State University, and was the director of nursing professional staff resources at the University of Cincinnati, University Hospital.

Dr. Malone received her BSN from the College of Nursing and Health at the University of Cincinnati and earned her M.S. in Adult Psychiatric Nursing from Rutgers. She received her Ph.D. in Clinical Psychology from the University of Cincinnati and attended the Harvard Institute of Educational Management.

Dr. Malone has received numerous professional and educational honors during her career, including honorary doctorates from Georgetown University, University of Cincinnati, and University of District of Columbia. Recent fellowships include Fellow Ad Eundem of the Faculty of Nursing & Midwifery, Royal College of Surgeons, Ireland, and Fellow of the National Academy of Medicine. In 2020 she received the Linda Bates Parker Legend Award from the University of Cincinnati, she was honored as a Modern Healthcare Inaugural Minority Leaders Luminary, and she received the Lifetime Achievement Award, the Alpha Omega Chapter of Signa Theta Tau and The College of Nursing of Adelphi University. She has been ranked several times as one of the 100 Most Influential People in Healthcare by Modern Healthcare, which has also honored her as one of the Top 25 Women in Healthcare.

The Gail L. Warden Leadership Excellence Award committee was co-chaired by Peter W. Butler, Retired President Rush University Medical Center, and Jill Schwieters, NCHL Board Chair, JAS & Associates. The committee’s members are: Nancy Howell Agee, Carilion Clinic; Bob Clarke, Furst Group; Damond Boatright, SSM Health – Wisconsin Regional; Dr. Joanne Conroy, Dartmouth-Hitchcock Health; Edgar Curtis, Memorial Health System; David Ertel, Vizient, Inc.; Jessica Melton, Sentara Norfolk General Hospital; Dr. David Feinberg, Google Health; Dr. Rod Hochman, Providence and 2019 Gail L. Warden Leadership Excellence Award recipient; Michelle Hood, American Hospital Association; Shoou-Yih (Daniel) Lee, PhD, Department of Health Management and Policy, University of Michigan School of Public Health; Joe Moscola, Northwell Health; and Brian Peters, Michigan Health and Hospital Association.

Dr. Malone will be honored at NCHL’s 2020 Gail L. Warden Leadership Award Celebration, which will occur virtually on Thursday, November 19, as part of the NCHL Human Capital Investment Conference being held November 16-20. Over the years, the conference and celebration have been one of healthcare’s most important events, attracting luminaries and notable leaders from prominent health sector, academic, and research organizations.

ABOUT THE GAIL L. WARDEN LEADERSHIP EXCELLENCE AWARD    

Established in 2005, NCHL’s annual Gail L. Warden Leadership Excellence Award recognizes individuals who have made significant contributions to the health field, including the mentoring of future leaders towards transforming organizational performance to improve health and healthcare. It is named for Gail L. Warden, founding chairman of the NCHL Board, president emeritus of Henry Ford Health System, and a major proponent of leadership development throughout his career.

ABOUT THE NATIONAL CENTER FOR HEALTHCARE LEADERSHIP

Established in 2001, the not-for-profit National Center for Healthcare Leadership champions three premier membership programs that advance healthcare leadership. These are the Leadership Excellence Networks (LENS), US Cooperative of International Patient Programs (USCIPP), and National Council on Administrative Fellowships (NCAF). Each of these programs supports a portfolio of interorganizational collaborations that address critical issues facing today’s leaders as they pursue excellence and solutions. For more information please visit NCHL’s website. You can also visit NCHL’s LinkedIn page or follow NCHL on Twitter.

“Dr. John Henry has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson

PLEASANTON, Calif. (PRWEB)
August 10, 2020

NeoTract, a wholly owned subsidiary of Teleflex Incorporated (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced that John Henry, M.D., Center for Urologic Care of Berks County in Wyomissing, PA, has been designated as a UroLift® Center of Excellence. The designation recognizes that Dr. Henry has achieved a high level of training and experience with the UroLift® System and demonstrated a commitment to exemplary care for men suffering from symptoms associated with Benign Prostatic Hyperplasia (BPH), also known as enlarged prostate.

Recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines, the FDA-cleared Prostatic Urethral Lift procedure using the UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to BPH. The UroLift permanent implants, delivered during a transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue.

The UroLift Center of Excellence program is designed to highlight urologists who are committed to educating their patients on BPH and the UroLift System as a treatment option and consistently seek to deliver excellent patient outcomes and experiences.

“Dr. John Henry has earned the UroLift Center of Excellence designation for his dedication to improving the lives of men who previously suffered from BPH symptoms and delivering superior patient outcomes with the UroLift System treatment,” said Dave Amerson, president of the Teleflex Interventional Urology business unit.

Over 40 million men in the United States are affected by BPH, a condition that occurs when the prostate gland that surrounds the male urethra becomes enlarged with advancing age and begins to obstruct the urinary system. Symptoms of BPH often include interrupted sleep and urinary problems and can cause loss of productivity, depression and decreased quality of life.

Medication is often the first-line therapy for enlarged prostate, but relief can be inadequate and temporary. Side effects of medication treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts, heats or removes prostate tissue to open the blocked urethra. While current surgical options can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction, and retrograde ejaculation.

About the UroLift® System

The FDA-cleared UroLift System is a proven, minimally invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia (BPH). The UroLift permanent implants, delivered during a minimally invasive transurethral outpatient procedure, relieve prostate obstruction and open the urethra directly without cutting, heating, or removing prostate tissue. Clinical data from a pivotal 206-patient randomized controlled study showed that patients with enlarged prostate receiving UroLift implants reported rapid and durable symptomatic and urinary flow rate improvement without compromising sexual function*1,2. Patients also experienced a significant improvement in quality of life. Over 100,000 men have been treated with the UroLift System in the U.S. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. The Prostatic Urethral Lift procedure using the UroLift System is recommended for the treatment of BPH in both the American Urological Association and European Association of Urology clinical guidelines. The UroLift System is available in the U.S., Europe, Australia, Canada, Mexico and South Korea. Learn more at http://www.UroLift.com.

About NeoTract | Teleflex Interventional Urology

A wholly owned subsidiary of Teleflex Incorporated, the Interventional Urology Business Unit is dedicated to developing innovative, minimally invasive and clinically effective devices that address unmet needs in the field of urology. Our initial focus is on improving the standard of care for patients with BPH using the UroLift System, a minimally invasive permanent implant system that treats symptoms while preserving normal sexual function*1,2. Learn more at http://www.NeoTract.com.

About Teleflex Incorporated

Teleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular and interventional access, surgical, anesthesia, cardiac care, urology, emergency medicine and respiratory care. Teleflex employees worldwide are united in the understanding that what we do every day makes a difference. For more information, please visit http://www.teleflex.com.

Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®, Pilling®, Rusch®, UroLift® and Weck® – trusted brands united by a common sense of purpose

For Teleflex Incorporated: Jake Elguicze, 610.948.2836

Treasurer and Vice President, Investor Relations

Media:

Nicole Osmer, 650.454.0504

nicole@healthandcommerce.com

*No instances of new, sustained erectile or ejaculatory dysfunction

1. Roehrborn, J Urology 2013 LIFT Study

2. McVary, J Sex Med 2016

MAC00968-01 Rev A

Share article on social media or email:

We’re pleased to once again be offering coverage of the ISMRM annual meeting. This year’s virtual format for ISMRM 2020 is a perfect complement to our exclusively online coverage.

ARLINGTON, Va. (PRWEB)
August 10, 2020

For the second straight year, radiology portal AuntMinnie.com, part of Science and Medicine Group, has launched a new special section dedicated exclusively to the proceedings of the International Society for Magnetic Resonance in Medicine (ISMRM) annual meeting.

AuntMinnie’s RADCast@ISMRM is available at radcast.auntminnie.com and features wall-to-wall editorial coverage of the premier medical conference dedicated exclusively to MRI. Important topics at the 2020 conference include the following:

• Alternatives to gadolinium-based MRI contrast
• Reducing the ecological impact of MRI scanners
• MRI in low-resource countries
• New applications of artificial intelligence and MRI
• Holographic visualization of human anatomy
• Efforts to improve the safety of MRI scanning

“We’re pleased to once again be offering coverage of the ISMRM annual meeting,” said Brian Casey, editor in chief of AuntMinnie.com. “This year’s virtual format for ISMRM 2020 is a perfect complement to our exclusively online coverage.”

ISMRM’s mission to educate the MRI community continues with this year’s virtual meeting, even in an era of social distancing, according to Lawrence L. Wald, PhD, 2019-2020 ISMRM president.

“Sharing research, networking, precipitating new thinking, and inspiring thought that does not come easily in isolation — that is the goal of our annual meeting,” Wald said. “It’s been a challenging year for all of us, with plenty of isolation, but I am confident that the virtual meeting can achieve these goals. I look forward to participating in it with you. It has been an honor serving the society as the 2019-2020 ISMRM president.”

AuntMinnie’s daily editorial coverage of ISMRM 2020 will run from August 8 to August 14.

About AuntMinnie.com

AuntMinnie.com is the premier online destination for radiologists, radiation therapists, interventional radiologists, and related professionals in the medical imaging industry, while AuntMinnieEurope.com serves the European radiology community. AuntMinnie.com and AuntMinnieEurope.com feature the latest news, communities, continuing medical education, and board review education for medical imaging physicians, clinicians, residents, and medical students across the world. AuntMinnie.com and AuntMinnieEurope.com are part of Science and Medicine Group.

Share article on social media or email:

“Comparing month-to-month numbers (June 2020 to July 2020), we see a leveling off of the employment-to-population ratio for people with and without disabilities, which may reflect regional resurgences of COVID-19 infections and restrictions of economic activity.” -John O’Neill, Kessler Foundation

EAST HANOVER, N.J. (PRWEB)
August 07, 2020

Kessler Foundation and University of New Hampshire nTIDE Report—featuring the Just in Time Employment Supports Project, a multi-state project of the University of Iowa Midwest Disability Employment Consortium that implements virtual networks to support job coaches, workers, and employers

July job numbers raise concerns about long-term employment prospects for Americans with disabilities, according to today’s National Trends in Disability Employment – Monthly Update (nTIDE), issued by Kessler Foundation and the University of New Hampshire’s Institute on Disability (UNH-IOD). Prolonged unemployment may discourage workers, causing them to stop looking for work.

nTIDE COVID Update (month-to-month comparison)

In the Bureau of Labor Statistics (BLS) Jobs Report released Friday, the employment-to-population ratio for working-age people with disabilities decreased from 28.4 percent in June 2020 to 28.1 percent in July 2020 (down 1.1 percent or 0.3 percentage points). For working-age people without disabilities, the employment-to-population ratio increased from 67.7 percent in June 2020 to 68.4 percent in July 2020 (up 1 percent or 0.7 percentage points). The employment-to-population ratio, a key indicator, reflects the percentage of people who are working relative to the total population (the number of people working divided by the number of people in the total population multiplied by 100).

“Comparing month-to-month numbers (June 2020 to July 2020), we see a leveling off of the employment-to-population ratio for people with and without disabilities, which may reflect regional resurgences of COVID-19 infections and restrictions of economic activity,” said John O’Neill, PhD, director of employment and disability research at Kessler Foundation. “This is in contrast to the last several months, where we saw month-to-month improvements,” he added.

The labor force participation rate for working-age people with disabilities decreased from 34.4 percent in June 2020 to 33.0 percent in July 2020 (down 4.1 percent or 1.4 percentage points). For working-age people without disabilities, the labor force participation rate also increased from 76.2 percent in June 2020 to 76.4 percent in July 2020 (up 0.3 percent or 0.2 percentage points). The labor force participation rate is the percentage of the population that is working, not working and on temporary layoff, or not working and actively looking for work.

“A decrease in the labor force participation rate for people with disabilities raises a red flag,” cautioned economist Andrew Houtenville, PhD, research director of the University of New Hampshire’s Institute on Disability. “It suggests that workers are losing their jobs permanently after being on furlough, and have stopped looking for work and thus, exited the labor force,” “With the potential impact of the recent surges in COVID-19 cases, we should be concerned about long-term employment stress for people with disabilities.”

nTIDE August COVID Update – Friday, August 21 at 12:00 pm Eastern

Stay tuned for more about the employment of people with disabilities as we follow the impact of COVID-19 and look at the numbers in more detail.

Traditional nTIDE Numbers (comparison to the same time last year)

The employment-to-population ratio for working-age people with disabilities decreased from 31.2 percent in July 2019 to 28.1 percent in July 2020 (down 9.9 percent or 3.1 percentage points). For working-age people without disabilities, the employment-to-population ratio also decreased from 74.9 percent in July 2019 to 68.4 percent in July 2020 (down 8.7 percent or 6.5 percentage points).

The labor force participation rate for working-age people with disabilities decreased from 34.1 percent in July 2019 to 33 percent in July 2020 (down 3.2 percent or 1.1 percentage points). For working-age people without disabilities, the labor force participation rate also decreased from 77.9 percent in July 2019 to 76.4 percent in July 2020 (down 1.9 percent or 1.5 percentage points).

For reference, July 2020, among workers ages 16-64, the 4,063,000 workers with disabilities represented 3.0 percent of the total 134,977,000 workers in the U.S.    

Beyond the Numbers

The impact of the COVID-19 pandemic on the U.S. labor market is profound and ongoing. Millions of workers are affected across all sectors, with recovery hindered by resurgent outbreaks in the majority of states. Most severely affected are populations characterized by the intersections of race, poverty, and disability, and the organizations and agencies that support their transition to competitive employment and maximal independence. Technology has emerged as fundamental to the viability of businesses and nonprofit organizations, and to the ability of individuals to stay engaged in the labor force.

As the pandemic triggered lockdowns and closures, the advantages for individuals and organizations with technology-based work flows were immediately apparent, according to Elaine E. Katz, MS, CCC-SLP, senior vice president of the Center for Grants and Communications at Kessler Foundation. The majority of the Foundation’s recent COVID-19 emergency grants went to grantees with acute needs for computers, mobile technology, and internet connectivity.

Well in advance of the pandemic, the Foundation was aware of the potential for technology to improve the outcomes of disability employment initiatives. In 2017, a Kessler Foundation Signature Employment Grant funded the Just in Time Employment Supports Project, a multi-state project of the University of Iowa Midwest Disability Employment Consortium, funded through the State University of Iowa. The Consortium partnered with the University Centers for Excellence in Developmental Disabilities of Iowa, Nebraska, and South Dakota, to pilot the use of mobile technology, such as cell phones and tablets, as well apps for facilitating direct communication, to create virtual networks of support for job coaches, workers, and other stakeholders.

The two-year Just in Time Project yielded valuable information about the many ways that utilization of mobile technology in supported employment can encourage open communication, enable timely interventions, and foster greater independence for people with disabilities.

“We recognized that the integration of virtual platforms offered through Just in Time Supports was a way to improve employment outcomes. Incorporating communications technology means job coaches can maintain close contact with colleagues and clients, providing timely support that benefits workers and employers,” Katz said. “The ability to connect remotely means coaches can serve more clients, including those in rural areas, and provide more efficient services.”

The COVID-19 pandemic casts a new light on the findings of the Just in Time Support Project. “The use of technology in disability employment initiatives is no longer optional,” Katz asserted, “it’s essential.”

The Project’s structure and scale yielded another important asset − the Consortium has established a large and functional network throughout the Midwest. ‘The ability to act collectively will be of critical importance,” Katz added, “as the stakeholders in disability employment deal with the challenges and opportunities of the COVID economy.”

Ask Questions about Disability and Employment

Join our nTIDE Lunch & Learn series today, August 7, at 12:00 pm Eastern. This live broadcast, hosted via Zoom Webinar, offers attendees Q&A on the latest nTIDE findings, provides news and updates from the field, as well as invited panelists to discuss current disability-related findings and events. Wendy Parent-Johnson, PhD, director of the Sonoran University Center Excellence in Developmental Disabilities at the University of Arizona, and Julie J. Christensen, LMSW, PhD, director of Policy and advocacy at APSE, join Dr. Houtenville, Dr. O’Neill, and Denise Rozell, Policy Strategist at AUCD. Join live or watch the recordings at: ResearchonDisability.org/nTIDE.

NOTE: The statistics in the nTIDE are based on Bureau of Labor Statistics numbers but are not identical. They are customized by UNH to combine the statistics for men and women of working age (16 to 64). nTIDE is funded, in part, by grants from the National Institute on Disability, Independent Living and Rehabilitation Research (NIDILRR) (90RT5037) and Kessler Foundation.

About Kessler Foundation

Kessler Foundation, a major nonprofit organization in the field of disability, is a global leader in rehabilitation research that seeks to improve cognition, mobility, and long-term outcomes — including employment — for people with neurological disabilities caused by diseases and injuries of the brain and spinal cord. Kessler Foundation leads the nation in funding innovative programs that expand opportunities for employment for people with disabilities. For more information, visit KesslerFoundation.org.

About the Institute on Disability at the University of New Hampshire

The Institute on Disability (IOD) at the University of New Hampshire (UNH) was established in 1987 to provide a coherent university-based focus for the improvement of knowledge, policies, and practices related to the lives of persons with disabilities and their families. For information on the NIDILRR-funded Employment Policy and Measurement Rehabilitation Research and Training Center, visit ResearchonDisability.org.

For more information, or to interview an expert, contact:

Carolann Murphy, 973.324.8382, CMurphy@KesslerFoundation.org.

The RSSearch Registry continues to grow and is a valuable resource for multi-institutional observational studies and prospective clinical trials investigating stereotactic radiotherapy and advancing therapies.

SAN JOSE, Calif. (PRWEB)
August 07, 2020

The Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science and clinical practice of radiosurgery, today announced that the MRI-Linac Consortium will use the Radiosurgery Society’s RSSearch Patient Registry as a centralized database to collect and track treatment delivery and outcomes of patients treated with the MRI-guided radiotherapy.

The MRI-Linac Consortium will be entering prospective and retrospective data on subjects treated with MRI-guided radiotherapy across multiple tumor sites. Combining data from multiple centers will allow the consortium members to analyze the collective data and publish their findings, which will include many of the first patients treated using this MRI-guided radiotherapy. The Consortium’s initial project will focus on gastrointestinal tumors, specifically pancreas and oligometastatic disease, to explore the clinical utility of MRI-guided radiotherapy on these traditionally difficult to treat indications.

“We are embarking on a unique collaboration with the Radiosurgery Society and ViewRay to advance the science and clinical practice of MRI-guided radiotherapy,” said Michael Chuong, M.D., Director of the MRI-Guided Radiation Therapy Program at Miami Cancer Institute and member of the ViewRay Gastrointestinal Cancer Consortium. “The RSSearch Registry provides a comprehensive and flexible system where we can use existing data fields and also customize new ones specific to our study, which will facilitate the analysis of patients treated on MRIdian at various institutions across the globe. Through our contributions to the RSSearch Registry, we hope to demonstrate how MRIdian can achieve substantial clinical benefit for cancer patients.”

The RSSearch Patient Registry is an observational multi-institutional registry established to standardize data collection from patients treated with stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT). With data from more than 25,000 patient cases treated with SRS/SBRT, the RSSearch Patient Registry is the largest and most robust live database of its kind in the field of SRS/SBRT managed by a professional medical society.

“We are excited to support the research efforts of the Consortium to advance the field of MRI- guided radiotherapy as a new technology for cancer treatments and patient care. The RSSearch Registry continues to grow and is a valuable resource for multi-institutional observational studies and prospective clinical trials investigating stereotactic radiotherapy and advancing therapies,“ said Iris Gibbs, M.D., President of the RSS Board of Directors.

The RSSearch Patient Registry collects information including patient demographics, lesion characteristics, treatment practices and outcome information including local control, disease progression, survival, toxicity and patient-reported quality of life information. Aggregate data analysis has resulted in several publications on clinical outcomes for radiosurgery treatment of lung tumors, liver metastases, metastatic brain tumors, recurrent head and neck cancer and prostate cancer.

Initially conceptualized and designed in 2005 by a Clinical Advisory Board comprised of radiation oncologists, neurosurgeons, medical oncologists and medical physicists, the RSSearch Patient Registry provides a method to collect standardized data on the use of SRS/SBRT treatment practices and outcomes to help determine its most effective clinical use.

The RSSearch Patient Registry is managed by the RSS and the RSSearch Clinical Advisory Committee, made up of professionals involved in the management and care of patients treated with SRS/SBRT. The registry currently has 26 active sites and more than 80 trained users. Participation in the registry is voluntary and all centers treating patients with SRS/SBRT clinically are encouraged to participate. The RSSearch Patient Registry is listed on ClinicalTrials.gov (Identifier (NCT number): NCT01885299).

Interested centers should contact Jan Jenkins, RN, Clinical Program Manager at the Radiosurgery Society at jjenkins@therss.org.

About The Radiosurgery Society®

The Radiosurgery Society (RSS) – a non-profit, independent, multi-disciplinary organization of surgeons, radiation oncologists, physicists, and allied professionals, who are dedicated to advancing the science and clinical practice of radiosurgery. Originally formed in 2002 and becoming (501c6) in 2008, the Radiosurgery Society today (http://www.therss.org) represents approximately 600 members who perform stereotactic body radiotherapy and radiosurgery in hospitals and freestanding centers throughout the world.

Share article on social media or email: